Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7637967rdf:typepubmed:Citationlld:pubmed
pubmed-article:7637967lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:7637967lifeskim:mentionsumls-concept:C0013295lld:lifeskim
pubmed-article:7637967lifeskim:mentionsumls-concept:C0380603lld:lifeskim
pubmed-article:7637967lifeskim:mentionsumls-concept:C0205227lld:lifeskim
pubmed-article:7637967lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:7637967pubmed:issue28lld:pubmed
pubmed-article:7637967pubmed:dateCreated1995-9-13lld:pubmed
pubmed-article:7637967pubmed:abstractTextAuthors investigated the role of endogenous bFGF in the development of experimental duodenal ulcer induced by cysteamine. The changes in endogenous bFGF in duodenum were examined by immunohistochemical method in the early stages of ulceration. A significant decrease was found in the immunoreactivity of bFGF in rat duodenal mucosa 12 and 24 hr after the administration of the duodenal ulcerogen cysteamine. Thus, in addition to being a novel potent pharmacologic agent, bFGF may play a pathophysiologic role in ulcer pathogenesis and healing.lld:pubmed
pubmed-article:7637967pubmed:languagehunlld:pubmed
pubmed-article:7637967pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7637967pubmed:citationSubsetIMlld:pubmed
pubmed-article:7637967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7637967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7637967pubmed:statusMEDLINElld:pubmed
pubmed-article:7637967pubmed:monthJullld:pubmed
pubmed-article:7637967pubmed:issn0030-6002lld:pubmed
pubmed-article:7637967pubmed:authorpubmed-author:SzabóSSlld:pubmed
pubmed-article:7637967pubmed:authorpubmed-author:SándorZZlld:pubmed
pubmed-article:7637967pubmed:authorpubmed-author:SakoulasGGlld:pubmed
pubmed-article:7637967pubmed:authorpubmed-author:KusstatscherS...lld:pubmed
pubmed-article:7637967pubmed:issnTypePrintlld:pubmed
pubmed-article:7637967pubmed:day9lld:pubmed
pubmed-article:7637967pubmed:volume136lld:pubmed
pubmed-article:7637967pubmed:ownerNLMlld:pubmed
pubmed-article:7637967pubmed:authorsCompleteYlld:pubmed
pubmed-article:7637967pubmed:pagination1501-3lld:pubmed
pubmed-article:7637967pubmed:dateRevised2009-10-21lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:meshHeadingpubmed-meshheading:7637967-...lld:pubmed
pubmed-article:7637967pubmed:year1995lld:pubmed
pubmed-article:7637967pubmed:articleTitle[Role of endogenous basic fibroblast growth factor in experimental duodenal ulcer].lld:pubmed
pubmed-article:7637967pubmed:affiliationDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.lld:pubmed
pubmed-article:7637967pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7637967pubmed:publicationTypeEnglish Abstractlld:pubmed